Correlation Between Sana Biotechnology and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Abcellera Biologics, you can compare the effects of market volatilities on Sana Biotechnology and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Abcellera Biologics.
Diversification Opportunities for Sana Biotechnology and Abcellera Biologics
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sana and Abcellera is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Abcellera Biologics
Given the investment horizon of 90 days Sana Biotechnology is expected to generate 1.66 times more return on investment than Abcellera Biologics. However, Sana Biotechnology is 1.66 times more volatile than Abcellera Biologics. It trades about -0.01 of its potential returns per unit of risk. Abcellera Biologics is currently generating about -0.05 per unit of risk. If you would invest 402.00 in Sana Biotechnology on September 25, 2024 and sell it today you would lose (244.00) from holding Sana Biotechnology or give up 60.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sana Biotechnology vs. Abcellera Biologics
Performance |
| Timeline |
| Sana Biotechnology |
| Abcellera Biologics |
Sana Biotechnology and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sana Biotechnology and Abcellera Biologics
The main advantage of trading using opposite Sana Biotechnology and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| Sana Biotechnology vs. Fate Therapeutics | Sana Biotechnology vs. Caribou Biosciences | Sana Biotechnology vs. Arcus Biosciences | Sana Biotechnology vs. Karyopharm Therapeutics |
| Abcellera Biologics vs. Fate Therapeutics | Abcellera Biologics vs. Caribou Biosciences | Abcellera Biologics vs. Arcus Biosciences | Abcellera Biologics vs. Karyopharm Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |